Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Midodrine for prevention of septic shock in children with severe sepsis
IRCT20120520009801N14Phase 3Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, triple-blind trial in sepsis and septic shock comparing Midodrine + standard care with Placebo + standard care (2 arms). Primary endpoint: Frequency of septic shock. Started Jun 2024; status: completed.
02
Drugs
midodrine
03
Conditions
sepsisseptic shock
Beyond the preview
Go deeper on IRCT20120520009801N14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20120520009801N14.